Genfit S A (GNFT) Return on Assets ROA from the fourth quarter of 2024 to fourth quarter of 2023 and for the year 2024, Average High and Low, Fundamental Ratios from Dec 31 2024 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Genfit S a   (NASDAQ: GNFT)


Genfit S A 's ROA from the fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Genfit S A 's ROA in the fourth quarter of 2024?
Genfit S a achieved a return on average assets (ROA) of 1 % in its fourth quarter of 2024, this is above GNFT's average return on assets of -10.74%.
Genfit S A assets over the 12 months ending in its fourth quarter of 2024 are valued at $170 million

ROA has improved compared to -18.4% in the third quarter of 2024, due to net income growth.

However, within the Healthcare sector 209 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2024 from to 2542.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Total Assets Change -12.91 % -12.91 % -12.91 % -12.91 % -19.33 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 2 -32 -32 -32 -32
Return On Assets (TTM) 1 % -18.4 % -17.76 % -17.17 % -16.62 %
GNFT's Total Ranking # 2542 # # # # 4236
Total Assets (TTM) in million 170 170 170 170 195
Seq. Total Assets Change 0 % 0 % 0 % -12.91 % 0 %
Seq. Net Income Change - - - - -

GNFT's 5 Years Annual ROA >> Back to GNFT Management Effectiveness >> Compare GNFT ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 21
Sector # 210
Overall # 2513

Return On Assets Statistics
High Average Low
23.87 %
-10.74 %
-50.96 %
(Dec 31 2021)   (Dec 31 2020)





Financial Statements
Genfit S A 's Assets $ 170 million GNFT's Balance sheet
Genfit S A 's Income $ 2 million Quarterly GNFT's Income Statement
GNFT's Income by Division See GNFT's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020
Y / Y Total Assets Change -12.91 % -19.33 % 124.7 % -24.41 % -25.4 %
Total Assets in million 170 195 241 107 142
Y / Y Net Income Change - - - - -
Net Income in million 2 -32 -27 75 -113
Annual Return On Assets 1 % -16.62 % -11 % 70.12 % -79.77 %

GNFT's 5 Years Annual ROA >> Back to GNFT Management Effectiveness >> Compare GNFT ROA to its Competitors



Comment on GNFT's ROA in the fiscal year ending 2024
In the fiscal year 2024 ROA improved to 1 % compared to prior year, due to annual net income growth of % to $1.69 million, and due to decline of value in Genfit S A 's assets by -12.91 % to $169.59 million, compared to $169.59 a year before.


More Return On Assets Ratios
GNFT's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GNFT's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GNFT's Competitors
Subscribers only: Roa for Genfit S A 's Suppliers
Subscribers only: Return On Assets for GNFT's Customers

You may also want to know
GNFT's Roi GNFT's Inventory Turnover Ratio GNFT's Growth Rates GNFT's Dividend Comparisons
GNFT's Profitability Ratios GNFT's Asset Turnover Ratio GNFT's Dividend Growth
GNFT's Roe GNFT's Valuation Ratios GNFT's Financial Strength Ratios GNFT's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2024, within Healthcare Sector ROA
Dynavax Technologies Corporation  2.70 %
Vericel Corporation  2.66 %
American Shared Hospital Services  2.61 %
Livanova Plc  2.54 %
Elanco Animal Health Incorporated  2.52 %
Zynex inc   2.41 %
Infusystem Holdings Inc  2.22 %
Fresenius Medical Care Ag  2.21 %
Adapthealth Corp   2.11 %
Revvity Inc  2.08 %
Bruker Corporation  2.04 %
Globus Medical Inc   2.03 %
Phibro Animal Health Corporation  1.98 %
Veracyte Inc   1.93 %
Innoviva Inc   1.86 %
Amedisys Inc  1.80 %
Galapagos Nv  1.79 %
Viskase Holdings inc   1.65 %
Privia Health Group Inc   1.55 %
Qiagen N v   1.47 %
Sotera Health Company  1.44 %
Pacs Group Inc   1.40 %
Vaso Corporation  1.27 %
Radnet Inc   1.22 %
Aurinia Pharmaceuticals Inc   1.08 %
Genfit S a   1.00 %
Grifols Sa  0.99 %
Teleflex Incorporated  0.94 %
Penumbra Inc  0.91 %
Gilead Sciences Inc   0.86 %

Date modified: 2026-09-18T13:11:06+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.